Research paperAssociation of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding
References (34)
- et al.
The granulocyte responses to the phosphodiesterase inhibitor RO 20-1724
J Allergy Clin Immunol
(1981) - et al.
Interaction of formylmethionylleucyl-phenylalanine, adenosine and phosphodiesterase inhibitors in human monocytes
FEBS Lett
(1989) - et al.
Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst
J Allergy Clin Immunol
(1990) - et al.
Inhibition of CD44, CD45, and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline
Int J Immunopharmacol
(1993) - et al.
The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells
Int J Immunopharmacol
(1993) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
Neuropharmacology
(1983)- et al.
Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast
J Biol Chem
(1992) - et al.
A low Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain
J Biol Chem
(1993) - et al.
Effects of solubilization and vanadate/glutathione complex on inhibitor potencies against eosinophil cyclic AMP-specific phosphodiesterase
FEBS Lett
(1992) - et al.
Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor
Int J Immunopharmacol
(1994)
Inhibition of human neutrophil degranulation by forskolin in the presence of phosphodiesterase inhibitors
Eur J Pharmacol
(1986)
Stereospecific binding of the antidepressant rolipram to brain protein structures
Eur J Pharmacol
(1986)
The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family
Gene
(1993)
Expression and regulation of human rat phosphodiesterase type IV isogenes
FEBS Lett
(1994)
Preliminary identification and role of phosphodiesterase isozymes in human basophils
J Immunol
(1992)
Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai
Naunyn Schmiedebergs Arch Pharmacol
(1991)
Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: Global evaluation of the preliminary reports
Curr Therap Res
(1985)
Cited by (104)
Phosphodiesterase inhibitors say NO to Alzheimer's disease
2019, Food and Chemical ToxicologyAccess to phthalazinones via palladium-catalyzed three-component cycloamino-carbonylation of 2-formylaryl tosylates, hydrazines and CO
2016, TetrahedronCitation Excerpt :Therefore, development of new methods for synthesis of phthalazinones and new phthalazinone derivatives is of broad interest. Since the first work by Heck and co-workers in 1974,6 palladium-catalyzed aminocarbonylation has become a powerful tool for the construction of the amide moiety in organic synthesis.7 In 2012, Beller and co-workers reported the synthesis of phthalazinone derivatives via Pd-catalyzed cycloaminocarbonylation of o-halobenzaldehydes and hydrazines using CO as a carbonyl source.8a
Inhibitory effects of hesperetin derivatives on guinea pig phosphodiesterases and Their ratios between high- and low-affinity rolipram binding
2013, Journal of Pharmaceutical SciencesDiscovery of a novel orally active PDE-4 inhibitor effective in an ovalbumin-induced asthma murine model
2012, European Journal of Pharmacology
Copyright © 1996 Published by Elsevier Inc.